Balliu, M., Calabresi, L., Bartalucci, N., Romagnoli, S., Maggi, L., Manfredini, R., . . . Vannucchi, A. M. (2021). Activated IL-6 signaling contributes to the pathogenesis of, and is a novel therapeutic target for, CALR-mutated MPNs. Blood Adv.

Balliu, Manjola, Laura Calabresi, Niccolò Bartalucci, Simone Romagnoli, Laura Maggi, Rossella Manfredini, Matteo Lulli, Paola Guglielmelli, και Alessandro Maria Vannucchi. "Activated IL-6 Signaling Contributes to the Pathogenesis Of, and Is a Novel Therapeutic Target For, CALR-mutated MPNs." Blood Adv 2021.

Balliu, Manjola, et al. "Activated IL-6 Signaling Contributes to the Pathogenesis Of, and Is a Novel Therapeutic Target For, CALR-mutated MPNs." Blood Adv 2021.